↓ Skip to main content

Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations

Overview of attention for article published in PharmacoEconomics, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
119 Mendeley
Title
Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations
Published in
PharmacoEconomics, June 2019
DOI 10.1007/s40273-019-00816-2
Pubmed ID
Authors

Jesse Elliott, Sasha van Katwyk, Bláthnaid McCoy, Tammy Clifford, Beth K. Potter, Becky Skidmore, George A. Wells, Doug Coyle

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 119 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 10%
Student > Master 11 9%
Student > Bachelor 11 9%
Researcher 10 8%
Other 10 8%
Other 16 13%
Unknown 49 41%
Readers by discipline Count As %
Medicine and Dentistry 22 18%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Nursing and Health Professions 9 8%
Neuroscience 4 3%
Social Sciences 4 3%
Other 15 13%
Unknown 55 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2019.
All research outputs
#13,651,493
of 23,150,406 outputs
Outputs from PharmacoEconomics
#1,428
of 1,868 outputs
Outputs of similar age
#175,659
of 353,107 outputs
Outputs of similar age from PharmacoEconomics
#13
of 25 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,868 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,107 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.